The use of adjuvant radiation therapy by members of the society of gynecologic oncologists

Gynecologic Oncology

Volumn 75, Issue 1, 1999, Pages 4-9

  Naumann, R Wendel ^a   Higgins, Robert V ^a   Hall, James B ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; ENDOMETRIUM CANCER; GYNECOLOGY; LYMPH NODE DISSECTION; ONCOLOGY; POSTOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0032831336     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5548     Document Type: Article

References (25)

1. Podratz K, Mariani A, Webb M. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol. 70:1998;163-164.
2. Landis S, Murray T, Bolden S, Wingo P. Cancer statistics, 1998. CA Cancer J Clin. 48:1998;6-29.
3. International Federation of Gynecology and Obstetrics. Corpus cancer staging. Int J Gynecol Obstet. 28:1989;190.
4. Roberts, J, A, Brunetto, V, L, Keys, H, M, Zaino, R, Spirtos, N, M, Bloss, J, D, Pearlman, A, Maiman, M, A, Bell, J, G, A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma. Abstracts of the 29th Annual Meeting of the Society of Gynecologic Oncologists, 35: 70, 1998, (abstract).
5. Morrow C P, Bundy B N, Kurman R J, Creasman W T, Heller P, Homesley H D, Graham J E. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 40:1991;55-65.
6. Doering D L, Barnhill D R, Weiser E B, Burke T W, Woodward J E, Park R C. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma. Obstet Gynecol. 74:1989;930-933.
7. Malviya V K, Deppe G, Malone J M Jr, Sundareson A S, Lawrence W D. Reliability of frozen section examination in identifying poor prognostic indicators in stage I endometrial adenocarcinoma. Gynecol Oncol. 34:1989;299-304.
8. Patsner B, Mann W J, Cohen H, Loesch M. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma. Am J Obstet Gynecol. 158:1988;399-402.
9. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P, Gadducci A. An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol. 68:1998;274-279.
10. Larson D M, Johnson K, Olson K A. Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet Gynecol. 79:1992;998-1001.
11. Sant Cassia L, Weppelmann B, Shingleton H, Soong S, Hatch K, Salter M. Management of early endometrial carcinoma. Gynecol Oncol. 35:1989;362-366.
12. Rose P, Cha S, Tak W, Fitzgerald T, Reale F, Hunter R. Radiation therapy for surgically proven para aortic node metastasis in endometrial carcinoma. Int J Radiat Oncol Biol Phys. 24:1992;229-233.
13. Corn B, Lanciano R, Greven K, Schultz D, Reisinger S, Stafford P, Hanks G. Endometrial cancer with para aortic adenopathy: patterns of failure and opportunities for cure. Int J Radiat Oncol Biol Phys. 24:1992;223-227.
14. Onda T, Yoshikawa H, Mizutani K, Mishima M, Yokota H, Nagano H, Ozaki Y, Murakami A, Ueda K, Taketani Y. Treatment of node positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer. 75:1997;1836-1841.
15. Kilgore L C, Partridge E E, Alvarez R D, Austin J M, Shingleton H M, Noojin F 3rd, Conner W. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 56:1995;29-33.
16. Larson D M, Broste S K, Krawisz B R. Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol. 91:1998;355-359.
17. Chen S S. Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri. No recurrence with only primary surgery. Cancer. 63:1989;1843-1845.
18. Trimble E, Kosary C, Park R. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol. 71:1998;339-343.
19. Gretz H Fr, Economos K, Husain A, Lesser M, Kaplan E, Caputo T A, Reynolds R K, Johnston C M, Pearl M L, Roberts J A. The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol. 61:1996;409-415.
20. Fanning J, Firestein S L. Cost-effective analysis of complete lymphadenectomy and brachytherapy in early endometrial cancer. Gynecol Oncol. 68:1998;128.
21. Barnes M N, Roland P Y, Alvarez R D, Robertson M W, Kilgore L C, Austin J M, Partridge E E. A comparison of treatment strategies for endometrial adenocarcinoma: a decision analysis. Gynecol Oncol. 68:1998;125.
22. Takeshima N, Hirai Y, Tanaka N, Yamawaki T, Yamauchi K, Hasumi K. Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion. Obstet Gynecol. 88:1996;280-282.
23. Creasman W T, Morrow C P, Bundy B N, Homesley H D, Graham J E, Heller P B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer. 60:1987;2035-2041.
24. Orr J. Surgical staging of endometrial cancer: does the patient benefit. Gynecol Oncol. 71:1998;335-339.
25. Partridge E, Jessup J, Donaldson E, Taylor P, Randall M, Braley P, Phillips J. 1996 Patient Care Evaluation Study (PCE) of cancer of the corpu uteri, National Cancer Database (NCDB), American College of Surgery. Gynecol Oncol. 72:1999;445.